Prediction: This Will Be SpaceX's Stock Price by the End of 2026

The article argues SpaceX needs much stronger revenue growth before justifying its valuation, projecting the stock could fall below its $150 opening price by end-2026. It cites 2026 revenue estimates of about $37B and notes that even a valuation of 50x sales implies a ~$1.85T market cap, roughly 14.5% below Monday’s close (to around $140). The bearish case is driven by weak/no near-term profitability, heavy AI spending (xAI/Grok) without meaningful ROI, and limited cash generation from Starlink.

Analysis

This is primarily a duration and funding-regime trade, not a clean operating-fundamentals call. When an asset trades on future optionality with limited current cash generation, valuation becomes highly elastic to risk appetite, and the first crack usually shows up in the multiple rather than the business. That makes SPCX vulnerable to a broader de-rating of unprofitable growth and AI-adjacent “promise capital,” while profitable AI monetizers like NVDA are better positioned if investors rotate toward proven cash conversion over narrative.

The near-term catalyst path is sentiment-driven: a softer tape, tighter private-market liquidity, or disappointment around AI return on capital can compress the stock over days to months. The 1-3 month risk is that early holders use any strength to reduce exposure, creating supply overhang without needing bad operating news. Over 6-18 months, the real falsifier is visible self-funding from the core business; absent that, the equity story risks becoming a funding story, with dilution and prioritization decisions substituting for growth.

Contrarianly, this may be more under-owned than the article implies if broader risk appetite snaps back and the company proves it can monetize at even a middling pace. But the consensus may be missing that markets rarely tolerate multiple expensive long-duration bets at once; if AI spend is being re-underwritten, the weakest cash-flow profile gets hit first. The cleaner expression is relative value: short the speculative duration, own the cash engine, and keep the thesis tied to disclosed cash flow or financing milestones rather than headline sentiment.

Key Decisions for Investors

• Initiate a SPCX/NVDA pair trade on any post-IPO strength: short SPCX vs. long NVDA for a 1-3 month horizon. Thesis is multiple compression in unprofitable growth, with NVDA acting as the higher-quality AI cash-flow hedge. Cover if SPCX begins trading consistently above the IPO-day range and management shows credible self-funding.
• If borrow or liquidity makes the short messy, use SPCX 3-6 month put spreads instead of outright short exposure. Target a defined-risk structure that benefits from a 10-15% de-rating in the next earnings/financing window.
• Set a hard invalidation trigger on SPCX: if disclosed revenue trajectory or financing terms imply the stock can sustain >40-50x forward sales without repeated capital raises, reduce or exit the bearish trade. The thesis depends on the market refusing to underwrite perpetual capex.
• Treat NDAQ as a sentiment barometer, not a primary trade. If IPO issuance and trading volumes improve, it is a warning that risk appetite is coming back and the SPCX de-rating trade should be scaled down.
• Do not short NVDA outright on this theme; if anything, use it as the long leg in a relative-value basket until there is evidence that AI spend is being punished indiscriminately rather than only the weakest monetizers.